Best practices for bioinformatic characterization of neoantigens for clinical utility.

Abstract excerpt

Neoantigens are newly formed peptides created from somatic mutations that are capable of inducing tumor-specific T cell recognition. Recently, researchers and clinicians have leveraged next generation sequencing technologies to identify neoantigens and to create personalized immunotherapies for cancer treatment. To create a personalized cancer vaccine, neoantigens must be computationally predicted from matched...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antigen Presentation
• Share to Antigens, Neoplasm